|
Group 1 (n = 27)
|
Group 2 (n = 13)
|
p-value
|
---|
Sex
| | |
0.58
|
Female
|
16 (59.26%)
|
8 (61.54%)
|
Male
|
11 (40.74%)
|
5 (38.46%)
|
Fracture-typea
| | |
0.32
|
Seinsheimer Type IIA
|
3
|
2
|
Seinsheimer Type IIB
|
1
|
2
|
Seinsheimer Type IIIA
|
10
|
3
|
Seinsheimer Type IIIB
|
–
|
1
|
Seinsheimer Type IV
|
2
|
–
|
Seinsheimer Type V
|
1
|
–
|
OTA-typea
| | |
0.54
|
32A1
|
1
|
2
|
32A2
|
–
|
–
|
32A3
|
3
|
2
|
32B2
|
10
|
4
|
32B3
|
2
|
–
|
32C2
|
–
|
–
|
32C3
|
1
|
–
|
Trauma mechanismb
| | |
0.61
|
Low energy
|
16
|
9
|
High energy
|
6
|
3
|
Nonunion-type
| | |
0.53
|
hypertrophic
|
3/27 (11.1%)
|
2/13 (15.4%)
|
atrophic
|
24/27 (88.9%)
|
11/13 (84.6%)
|
Age
|
64.96 ± 15.87
|
66.31 ± 12.66
|
0.35
|
BMIc
|
26.9 ± 5.41
|
29.91 ± 5.6
|
0.57
|
Time to index procedure (months)
|
10.37 ± 7.2
|
8.85 ± 5.77
|
0.67
|
Prior surgeries per particpant
|
0.22 ± 0.42
|
0.69 ± 1.18
|
0.21
|
Mean operation time (minutes)
|
156.74 ± 42.63
|
149.08 ± 41.36
|
0.59
|
Number of red blood cell units tranfused
|
2.96 ± 3.57
|
3.15 ± 3.46
|
0.87
|
Lenght of hospital stay (days)
|
14.74 ± 5.45
|
15.77 ± 8.64
|
0.89
|
Diabetes mellitus
|
3/27 (11.1%)
|
0/13 (0%)
|
0.54
|
Steroid use
|
3/27 (11.1%)
|
0/13 (0%)
|
0.54
|
Smoking
|
3/27 (11.1%)
|
3/13 (23.1%)
|
0.37
|
Osteoporosis
|
2/27(7.4%)
|
3/13(23.1%)
|
0.31
|
Bony healing
|
27/27(100%)
|
10/13(76.92%)
|
0.03
|
Healing time (months)
|
7.96 ± 6.53
|
23.11 ± 26.57
|
0.01
|
Follow-up (months)
|
21.48 ± 17.52
|
36.15 ± 50.7
|
0.54
|
- aincomplete dataset; in 15 participants Information could not be gathered due to incomplete medical records at admission to our clinic
- bincomplete dataset; in six participants Information could not be gathered due to incomplete medical records at admission to our clinic
- cincomplete dataset; in one participant Information could not be gathered due to incomplete medical records at admission to our clinic